HR
HAE icon

Howe & Rusling’s Haemonetics HAE Stock Holding History

Howe & Rusling’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32
Closed -$4K – 984
2021
Q1 		$4K Hold
32
– – ﹤0.01% 674
2020
Q4 		$4K Sell
32
-6
-16% -$646 ﹤0.01% 665
2020
Q3 		$3K Buy
38
+15
+65% +$1.31K ﹤0.01% 644
2020
Q2 		$2K Buy
+23
New +$2.32K ﹤0.01% 672
2017
Q2 		– Sell
-226
Closed -$9K – 979
2017
Q1 		$9K Hold
226
– – ﹤0.01% 525
2016
Q4 		$9K Sell
226
-204
-47% -$7.69K ﹤0.01% 526
2016
Q3 		$16K Buy
+430
New +$14.8K ﹤0.01% 413

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Howe & Rusling's HAE Position: Q2 2021 in Review

Howe & Rusling sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 32 shares — an estimated $4K sold.

Howe & Rusling first reported a position in HAE in Q3 2016 and held it in 7 quarters. The position peaked at $16K in Q3 2016. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Howe & Rusling reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Howe & Rusling sold 32 Haemonetics shares in Q2 2021, an estimated $4K.
  • Howe & Rusling first reported a position in Haemonetics in Q3 2016 and held it in 7 quarters.
  • Howe & Rusling's Haemonetics position peaked at $16K in Q3 2016.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Howe & Rusling's 13F filing for Q2 2021, filed 13 Aug 2021.